Redox regulation of protein kinase C by selenometabolites and selenoprotein thioredoxin reductase limits cancer prevention by selenium
- PMID: 29775743
- DOI: 10.1016/j.freeradbiomed.2018.05.062
Redox regulation of protein kinase C by selenometabolites and selenoprotein thioredoxin reductase limits cancer prevention by selenium
Abstract
The cancer-preventive mechanism of selenium should address the way low concentrations of selenometabolites react with cellular targets without being diffused from the sites of generation, the way selenium selectively kills tumor cells, and the intriguing U-shaped curve that is seen with dietary supplementation of selenium and cancer prevention. Protein kinase C (PKC), a receptor for tumor promoters, is well suited for this mechanism. Due to the catalytic redox cycle, low concentrations of methylselenol, a postulated active metabolite of selenium, react with the tumor-promoting lipid hydroperoxide bound to PKC to form methylseleninic acid (MSA), which selectively reacts with thiol residues present within the vicinity of the PKC catalytic domain to inactivate it. Given that lipid hydroperoxide levels are high in promoting cells, PKC inactivation selectively leads to death in these cells. A biphasic effect of MSA in inducing cell death was observed in certain prostate cancer cell lines; lower concentrations of MSA induced cell death, while higher concentrations failed to do so. Lower concentrations of selenium inactivate more sensitive antiapoptotic isoenzymes of PKC (ε and α), sparing less sensitive proapoptotic isoenzymes (PKCδ and PKCζ). Higher concentrations of selenium also inactivate proapoptotic isoenzymes and consequently make tumor cells resistant to apoptosis. Due to a high-affinity binding of thioredoxin to the PKC catalytic domain, this thiol oxidation is explicitly reversed by thioredoxin reductase (TXNRD), a selenoprotein. Therefore, overexpression of TXNRD in advanced tumor cells could make them resistant to selenium-induced death. Conceivably, this mechanism, at least in part, explains why selenium prevents cancer only in certain cases.
Keywords: Methylseleninic acid; Methylselenol; Prostate cancer prevention; Protein kinase C; Selenoproteins; Thioredoxin reductase.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
Locally generated methylseleninic acid induces specific inactivation of protein kinase C isoenzymes: relevance to selenium-induced apoptosis in prostate cancer cells.J Biol Chem. 2008 Dec 12;283(50):34519-31. doi: 10.1074/jbc.M807007200. Epub 2008 Oct 15. J Biol Chem. 2008. PMID: 18922790 Free PMC article.
-
Antioxidant regulation of protein kinase C in cancer prevention.J Nutr. 2002 Dec;132(12):3819S-3823S. doi: 10.1093/jn/132.12.3819S. J Nutr. 2002. PMID: 12468631
-
Imbalance in Protein Thiol Redox Regulation and Cancer-Preventive Efficacy of Selenium.React Oxyg Species (Apex). 2016;2(4):272-289. doi: 10.20455/ros.2016.851. Epub 2016 May 25. React Oxyg Species (Apex). 2016. PMID: 29795790 Free PMC article.
-
Protein kinase C as a molecular target for cancer prevention by selenocompounds.Nutr Cancer. 2001;40(1):55-63. doi: 10.1207/S15327914NC401_11. Nutr Cancer. 2001. PMID: 11799924 Review.
-
Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase.Carcinogenesis. 1999 Sep;20(9):1657-66. doi: 10.1093/carcin/20.9.1657. Carcinogenesis. 1999. PMID: 10469608 Review.
Cited by
-
Signaling pathway network alterations in human ovarian cancers identified with quantitative mitochondrial proteomics.EPMA J. 2019 Jun 8;10(2):153-172. doi: 10.1007/s13167-019-00170-5. eCollection 2019 Jun. EPMA J. 2019. PMID: 31258820 Free PMC article.
-
Antioxidant Status in Patients after Breast Mastopexy and Augmentation.Medicina (Kaunas). 2024 Jun 26;60(7):1046. doi: 10.3390/medicina60071046. Medicina (Kaunas). 2024. PMID: 39064475 Free PMC article.
-
A Review of Plant Selenium-Enriched Proteins/Peptides: Extraction, Detection, Bioavailability, and Effects of Processing.Molecules. 2023 Jan 26;28(3):1223. doi: 10.3390/molecules28031223. Molecules. 2023. PMID: 36770890 Free PMC article. Review.
-
Toxicology and pharmacology of synthetic organoselenium compounds: an update.Arch Toxicol. 2021 Apr;95(4):1179-1226. doi: 10.1007/s00204-021-03003-5. Epub 2021 Apr 1. Arch Toxicol. 2021. PMID: 33792762 Free PMC article. Review.
-
Plasma activity of Thioredoxin Reductase as a Novel Biomarker in Gastric Cancer.Sci Rep. 2019 Dec 13;9(1):19084. doi: 10.1038/s41598-019-55641-6. Sci Rep. 2019. PMID: 31836775 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources